{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:49:46Z","timestamp":1788684586068,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1985,8,1]],"date-time":"1985-08-01T00:00:00Z","timestamp":491702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1985,8,1]],"date-time":"1985-08-01T00:00:00Z","timestamp":491702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[1985,8]]},"DOI":"10.1378\/chest.88.2_supplement.103s","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T09:23:22Z","timestamp":1223717002000},"page":"103S-111S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"S","title":["Update on the Pharmacodynamics and Pharmacokinetics of Theophylline"],"prefix":"10.1016","volume":"88","author":[{"given":"Leslie","family":"Hendeles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Massanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.88.2_Supplement.103S_bib1","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.1980.03310200026020","article-title":"Treatment of chronic obstructive pulmonary disease with orally administered theophylline: a double-blind, controlled study","volume":"244","author":"Alexander","year":"1980","journal-title":"JAMA"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-92-6-758","article-title":"Efficacy of theophylline in \u201cirreversible\u201d airflow obstruction","volume":"92","author":"Eaton","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1378\/chest.82.5.538","article-title":"Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction","volume":"82","author":"Eaton","year":"1982","journal-title":"Chest"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib4","first-page":"600","article-title":"The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking","volume":"130","author":"Jenne","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib5","first-page":"22","article-title":"Sustained-release theophylline reduces dyspnea in non-reversible obstructive airway disease","volume":"131","author":"Mahler","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"suppl 109","key":"10.1378\/chest.88.2_Supplement.103S_bib6","first-page":"37","article-title":"Phosphodiesterase inhibition and theophylline","volume":"61","author":"Bergstrand","year":"1980","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0090-6980(77)90040-5","article-title":"Methylxanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation","volume":"13","author":"Horrobin","year":"1977","journal-title":"Prostaglandins"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI106808","article-title":"The stimulus-secretion coupling of glucose-induced insulin release. VII. A proposed site of action for adenosine 3\u20195\u2019-cyclic monophosphate","volume":"51","author":"Brisson","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib9","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1016\/0006-2952(79)90422-2","article-title":"Effect of theophylline on the binding of cAMP to soluble protein from tracheal smooth muscle","volume":"28","author":"Miech","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib10","first-page":"380","article-title":"Adenosine-induced bronchoconstriction in asthma","volume":"129","author":"Cushley","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00542541","article-title":"Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease","volume":"22","author":"Lunell","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0091-6749(84)90262-8","article-title":"Adenosine as a bronchoconstrictor mediator in asthma and its antagonism by methylxanthine","volume":"74","author":"Holgate","year":"1984","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl 109","key":"10.1378\/chest.88.2_Supplement.103S_bib13","first-page":"17","article-title":"Extrapulmonary effects of theophylline","volume":"61","author":"Andersson","year":"1980","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM198408093110601","article-title":"Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease","volume":"311","author":"Murciano","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0002-9343(78)90741-6","article-title":"Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease","volume":"65","author":"Matthay","year":"1978","journal-title":"Am J Med"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib16","first-page":"33","article-title":"Effect of aminophylline on ventilatory responses in normal man","volume":"117","author":"Lakshminarayan","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.35.2.365","article-title":"Hemodynamic effects of aminophylline in chronic obstructive pulmonary disease","volume":"35","author":"Parker","year":"1967","journal-title":"Circulation"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib18","series-title":"Sustained release theophylline in the treatment of CRAO","first-page":"22","article-title":"The effect of theophylline on mucociliary transport","author":"Clarke","year":"1984"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3476(74)80732-8","article-title":"Evaluation of oral bronchodilator therapy in asthmatic children","volume":"84","author":"Weinberger","year":"1974","journal-title":"J Pediatr"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1542\/peds.60.6.840","article-title":"Relationship of serum theophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn","volume":"60","author":"Pollock","year":"1977","journal-title":"Pediatrics"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(77)92601-0","article-title":"Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma","volume":"1","author":"Hambleton","year":"1977","journal-title":"Lancet"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJM198101083040202","article-title":"The value of maintenance theophylline in steroid-dependent asthma","volume":"304","author":"Nassif","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-3476(82)80142-X","article-title":"Comparison of orally administered metaproterenol and theophylline in the control of chronic asthma","volume":"101","author":"Dusdieker","year":"1982","journal-title":"J Pediatr"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/clpt.1982.81","article-title":"Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin","volume":"31","author":"Richer","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib25","first-page":"790","article-title":"Sustained-release theophylline for treatment of asthma in preschool children","volume":"136","author":"Simons","year":"1982","journal-title":"Am J Dis Child"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/cpt1975175585","article-title":"Interaction of ephedrine and theophylline","volume":"17","author":"Weinberger","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3476(82)80467-8","article-title":"Sustained release theophylline: a significant advance in the treatment of childhood asthma","volume":"100","author":"Tabachnik","year":"1982","journal-title":"J Pediatr"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib28","first-page":"1218","article-title":"Frequent toxicity from IV aminophylline infusions in critically ill patients","volume":"11","author":"Hendeles","year":"1977","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1378\/chest.73.6_Supplement.949","article-title":"The development of drug tolerance to beta2 adrenergic agents","volume":"73","author":"Plummer","year":"1978","journal-title":"Chest"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib30","first-page":"493","article-title":"Inhaled and oral salbutamol in exercise-induced asthma","volume":"114","author":"Anderson","year":"1976","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(85)90964-X","article-title":"Multifocal atrial tachycardia: a toxic effect of theophylline","volume":"1","author":"Levine","year":"1985","journal-title":"Lancet"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2125.1979.tb00893.x","article-title":"Impaired theophylline clearance in patients with cor pulmonale","volume":"7","author":"Vicuna","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM197810192991603","article-title":"The relation of product formulation to absorption of oral theophylline","volume":"299","author":"Weinberger","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003088-198409020-00001","article-title":"A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products","volume":"9","author":"Hendeles","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0022-3476(77)80527-1","article-title":"Relationship of theophylline clearance to oral dosage in children with chronic asthma","volume":"91","author":"Cinchansky","year":"1977","journal-title":"J Pediatr"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib36","first-page":"613","article-title":"Comparison of standard and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease","volume":"36","author":"Dasta","year":"1979","journal-title":"Am J Hosp Pharm"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-3476(81)80982-1","article-title":"Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma","volume":"99","author":"Weinberger","year":"1981","journal-title":"J Pediatr"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/j.1875-9114.1984.tb03353.x","article-title":"Theophylline qid, tid, bid and now qd? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24","volume":"4","author":"Weinberger","year":"1984","journal-title":"Pharmacotherapy"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib39","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.87.6.758","article-title":"Food-induced dumping from a \u201conce-a-day\u201d theophylline product as a cause of theophylline toxicity","volume":"85","author":"Hendeles","year":"1985","journal-title":"Chest"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1398-9995.1984.tb01985.x","article-title":"A pharmacokinetic study of the recommended dosing schedules of Theo-dur and Uniphylline","volume":"39","author":"Purkiss","year":"1984","journal-title":"Allergy"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib41","unstructured":"Karim A. Theophylline absorption, controlled-release formulations and food. Presented at the 3rd Annual Conference on Current Concepts in Biopharmaceutics and Clinical Trials, University of Maryland, Baltimore, Oct 4, 1984"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib42","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1542\/peds.74.4.534","article-title":"Erratic absorption of a slow release theophylline sprinkle product caused by food","volume":"74","author":"Pedersen","year":"1984","journal-title":"Pediatrics"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/j.1552-4604.1982.tb02162.x","article-title":"Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet","volume":"22","author":"Leeds","year":"1982","journal-title":"J Clin Pharmacol"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00548776","article-title":"Food does not affect bioavailability of theophylline from Theolin Retard","volume":"26","author":"Sips","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/bdd.2510040109","article-title":"Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects","volume":"4","author":"Osman","year":"1983","journal-title":"Biopharm Drug Dispos"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib46","unstructured":"Pedersen S, Moller-Pedersen J. Influence of food on the absorption of theophylline from Somophyllin-CRT. Clin Allergy (in press)"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1398-9995.1982.tb02336.x","article-title":"Influence of food on the absorption rate and bioavailability of a sustained release theophylline preparation","volume":"37","author":"Pedersen","year":"1982","journal-title":"Allergy"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2125.1983.tb01550.x","article-title":"The influence of antacid on the absorption of two different sustained-release formulations of theophylline","volume":"15","author":"Myhre","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib49","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/jps.2600700606","article-title":"Effect of antacid on bioavailability of theophylline from rapid and timed-release drug products","volume":"70","author":"Shargel","year":"1981","journal-title":"J Pharm Sci"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib50","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/clpt.1982.193","article-title":"Factors influencing theophylline serum protein binding","volume":"32","author":"Shaw","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/j.1875-9114.1983.tb04531.x","article-title":"Theophylline: a \u201cstate of the art\u201d review","volume":"3","author":"Hendeles","year":"1983","journal-title":"Pharmacotherapy"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib52","first-page":"500","article-title":"Pharmacokinetics and metabolism of theophylline in patients with liver diseases","volume":"18","author":"Staib","year":"1980","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib53","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0140-6736(78)90305-7","article-title":"Altered theophylline pharmacokinetics during acute respiratory viral illness","volume":"1","author":"Chang","year":"1978","journal-title":"Lancet"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00003088-198409040-00002","article-title":"Pharmacokinetic drug interactions with theophylline","volume":"9","author":"Jonkman","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/cpt1978244406","article-title":"Enhanced biotransformation of theophylline in marihuana and tobacco smokers","volume":"24","author":"Jusko","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/arrd.1983.127.4.417","article-title":"Theophylline disposition in cystic fibrosis","volume":"127","author":"Isles","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib57","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/clpt.1984.233","article-title":"Influence of thyroid function on theophylline kinetics","volume":"36","author":"Vozeh","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib58","first-page":"365","article-title":"Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline","volume":"122","author":"Rossing","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib59","unstructured":"Gonzalez MA, Golub AL, Meyer ML, Straughn AB. Disposition kinetics of controlled-release theophylline dosed at 12 and 24 hour dosing intervals [Abstract]. Presented at the 36th Annual Meeting of the APhA Academy of Pharmaceutical Sciences, Montreal, May, 1984 abstract p 108"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib60","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(84)91663-5","article-title":"Food-induced dose dumping of once-a-day theophylline [Letter]","volume":"2","author":"Hendeles","year":"1984","journal-title":"Lancet"},{"key":"10.1378\/chest.88.2_Supplement.103S_bib61","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJM198303313081306","article-title":"Slow-release theophylline: rationale and basis for product selection","volume":"308","author":"Weinberger","year":"1983","journal-title":"N Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216392169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216392169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:44:12Z","timestamp":1757922252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216392169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,8]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,8]]}},"alternative-id":["S0012369216392169"],"URL":"https:\/\/doi.org\/10.1378\/chest.88.2_supplement.103s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1985,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the Pharmacodynamics and Pharmacokinetics of Theophylline","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.88.2_Supplement.103S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1985 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}